Spexis investor relations
WebSep 6, 2024 · ALLSCHWIL, Switzerland, Sept. 06, 2024 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced its financial results for the first half of 2024 and provided a strategic business update.
Spexis investor relations
Did you know?
WebAug 31, 2024 · You have not yet registered? Get your account for free. Register Here WebNov 10, 2024 · Description. Spexis AG formerly Polyphor AG is a clinical stage biopharmaceutical company. The company is engaged in the discovery and development …
WebAug 31, 2024 · ALLSCHWIL, Switzerland, Aug. 31, 2024 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and … WebMar 24, 2024 · Spexis is a clinical-stage biopharmaceutical company based in Allschwil, Switzerland, focused on rare diseases and oncology. The current pipeline of the company …
WebJun 30, 2024 · ALLSCHWIL, Switzerland, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced its financial results for the first half of 2024 and provided a strategic business update. WebMar 24, 2024 · For Investors: Hernan Levett Chief Financial Officer Spexis AG. +41 61 567 16 00 [email protected] For Media: Dr. Stephan Feldhaus Feldhaus & Partner +41 79 865 92 56 [email protected] About Spexis Spexis is a clinical-stage biopharmaceutical company based in Allschwil, Switzerland, focused on rare diseases and oncology.
WebMar 9, 2024 · Spexis AG. +41 61 567 16 00 [email protected] For Media: Dr. Stephan Feldhaus Feldhaus & Partner +41 79 865 92 56 [email protected] About Spexis Spexis is a clinical-stage biopharmaceutical company based in Allschwil, Switzerland, focused on rare diseases and oncology.
WebAug 30, 2024 · Listen. Sections. U.S. News; World News; Politics; Sports; Entertainment; Business number of brigadier generals in the armyWebFeb 6, 2024 · Investor Relations MC: 31742 301 E Market Street Indianapolis, IN 46204 Investor Relations Cummins Inc. Chris Clulow Vice President, Investor Relations T: 812-377-3121 [email protected] [email protected] Transfer Agent Broadridge Shareholder Services T: 1-844-973-0592 [email protected] number of bridges spanning amazon riverWebPSG Konsult delivered a 5% increase in recurring headline earnings per share and a return on equity of 22.7% for the current year. Total assets under management increased by 13% to R354.1 billion, comprising assets managed by PSG Wealth of R305.5 billion (12% increase) and PSG Asset Management of R48.6 billion (16% increase), while PSG Insure’s gross … nintendo switch lite pricingWebSpexis > Investor Relations (placeholder) > Contact. Investors Relations. Hernan Levett Chief Financial Officer Spexis Ltd. Tel: +41 61 567 16 24 Email: [email protected] . Share Information. Interact with us. Partnering; Get our news; Join our … number of bridges in hamburgWebAug 31, 2024 · ALLSCHWIL, Switzerland, Aug. 31, 2024 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and … number of bridges in chinaWebSep 6, 2024 · ALLSCHWIL, Switzerland, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and … number of brightline crashesWebApr 11, 2024 · Investor Relations: Todd Spencer Corporate Vice President, Investor Relations 781.222.6455 [email protected]. Editor Details. Company: Businesswire; Last Updated: 11-Apr-2024 PharmiWeb.jobs About Us Contact Us Terms and Conditions ... nintendo switch lite puppies and kittens